In 1981, a high molecular weight protein expressed on the surface of ovarian cancer cells was recognized by a monoclonal antibody selectively targeting MUC16, and it was subsequently found to be elevated in the sera of ovarian cancer patients (8). The gene discussed is MUC16; the disease is ovarian cancer.